Grants per year
Fingerprint
Dive into the research topics where Christa Arguinchona is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
Research Output
- 7 Article
-
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group & ACTT-3 Study Group, Mar 2024, In: eClinicalMedicine. 69, 102472.Research output: Contribution to journal › Article › peer-review
Open Access -
A narrative review of high-level isolation unit operational and infrastructure features
Lukowski, J., Vasa, A., Arguinchona, C., Elrayes, W., Frank, M. G., Galdys, A. L., Garcia, M. C., Garland, J. A., Kline, S., Persson, C., Ruby, D., Sauer, L. M., Vasistha, S., Carrasco, S. & Herstein, J. J., Jul 9 2023, In: BMJ Global Health. 8, 7, e012037.Research output: Contribution to journal › Article › peer-review
Open Access -
Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response
Grein, J. D., Garland, J. A., Arguinchona, C., Frank, M. G., Garibaldi, B. T., Grindle, A., Hewlett, A., Kline, S., Levine, C. B., Mehta, A., Mukherjee, V., Sauer, L. M., Searle, E. F., Vanairsdale, S. & Vasa, A., Jun 1 2022, In: Health Security. 20, S1, p. S4-S12Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
ACTT-3 study group members, Dec 2021, In: The Lancet Respiratory Medicine. 9, 12, p. 1365-1376 12 p.Research output: Contribution to journal › Article › peer-review
Open Access108 Scopus citations -
Remdesivir for the treatment of COVID-19 — Final report
ACTT-1 Study Group Members, Essential Regulatory Documents Group Team (ERDG Team), DMID CROMS Study Information Office Team (SIO Team), Safety Oversight Committee Support Team (SOCS Team) & DMID CROMS Teleconferencing Team, Nov 5 2020, In: New England Journal of Medicine. 383, 19, p. 1813-1826 14 p.Research output: Contribution to journal › Article › peer-review
Open Access5016 Scopus citations